Readout Newsletter: Moderna, Vertex, Otsuka, Vera

Damian bids farewell in the final edition of The Readout at STAT after 8 years of covering biotech. Meghana Keshavan will continue the newsletter. European regulators find no link between new obesity medicines and suicidal thoughts. Moderna halts plans to invest in a Kenya manufacturing site for mRNA vaccines due to insufficient demand. Vertex Pharmaceuticals acquires Alpine Immune Sciences, shedding light on Vera Therapeutics. AstraZeneca CEO Pascal Soriot’s pay raises to $24 million. Drugmakers seek alternative suppliers as US cracks down on Chinese biotech. Enhertu receives pan-tumor approval. Oncologists use precision techniques for failed cancer drugs.

Source link

error: Content is protected !!